Senescent cells: An emerging target for diseases of ageing

Bennett G. Childs, Martina Gluscevic, Darren J. Baker, Remi Martin Laberge, Dan Marquess, Jamie Dananberg, Jan M. Van Deursen

Research output: Contribution to journalReview articlepeer-review

332 Scopus citations


Chronological age represents the single greatest risk factor for human disease. One plausible explanation for this correlation is that mechanisms that drive ageing might also promote age-related diseases. Cellular senescence, which is a permanent state of cell cycle arrest induced by cellular stress, has recently emerged as a fundamental ageing mechanism that also contributes to diseases of late life, including cancer, atherosclerosis and osteoarthritis. Therapeutic strategies that safely interfere with the detrimental effects of cellular senescence, such as the selective elimination of senescent cells (SNCs) or the disruption of the SNC secretome, are gaining significant attention, with several programmes now nearing human clinical studies.

Original languageEnglish (US)
Pages (from-to)718-735
Number of pages18
JournalNature Reviews Drug Discovery
Issue number10
StatePublished - Oct 1 2017

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Senescent cells: An emerging target for diseases of ageing'. Together they form a unique fingerprint.

Cite this